Cargando…

Aerosolized antibiotics in the treatment of hospital-acquired pneumonia/ventilator-associated pneumonia

Aerosolized antibiotics are being increasingly used to treat respiratory infections, especially those caused by drug-resistant pathogens. Their use in the treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in critically ill patients is especially significant. They are also...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Yun Jung, Kim, Eun Jin, Choi, Young Hwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747925/ https://www.ncbi.nlm.nih.gov/pubmed/34666432 http://dx.doi.org/10.3904/kjim.2021.277

Ejemplares similares

Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?
por: Vallecoccia, Maria Sole, et al.
Publicado: (2020)

Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
por: Motowski, Hayley, et al.
Publicado: (2023)

Didn’t inhale? Time to reconsider aerosolized antibiotics in the treatment of ventilator-associated pneumonia
por: Sweeney, Daniel A., et al.
Publicado: (2018)

Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia
por: Rubinstein, Ethan, et al.
Publicado: (2014)

Aerosolized antibiotics for ventilator-associated pneumonia: a pairwise and Bayesian network meta-analysis
por: Xu, Feng, et al.
Publicado: (2018)

Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes
por: Hyun, Hakjun, et al.
Publicado: (2022)

Outcomes and Prognostic Factors for Severe Community-Acquired Pneumonia that Requires Mechanical Ventilation
por: Lee, Jin Hwa, et al.
Publicado: (2007)

The current pathogens and treatment of hospital-acquired pneumonia/ventilator-associated pneumonia in medical intensive care units
por: Chang, Y, et al.
Publicado: (2015)

Narrative Review of the Epidemiology of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Gulf Cooperation Council Countries
por: Abdalla, Jehad S., et al.
Publicado: (2023)

Aerosolized antibiotics: do they add to the treatment of pneumonia?
por: Kollef, Marin H., et al.
Publicado: (2013)

Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia
por: Swanson, Joseph M., et al.
Publicado: (2013)

Predictors of Viral Pneumonia in Patients with Community-Acquired Pneumonia
por: Kim, Ji Eun, et al.
Publicado: (2014)

Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2020)

1472. Antibiotic De-escalation Compared with Continued Empirical Treatment in Non-Ventilated Hospital-Acquired Pneumonia
por: Alnaimi, Shaikha, et al.
Publicado: (2018)

Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia
por: Lee, Mi Suk, et al.
Publicado: (2018)

792 Predictors of viral pneumonia in patients with community-acquired pneumonia
por: Kim, Ji Eun, et al.
Publicado: (2014)

Clinical Efficacy of Cefoperazone-Sulbactam versus Piperacillin-Tazobactam in the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
por: Chen, Chia-Hung, et al.
Publicado: (2021)

Cost Effectiveness of Ceftolozane/Tazobactam Compared with Meropenem for the Treatment of Patients with Ventilated Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
por: Naik, Jaesh, et al.
Publicado: (2021)

Viruses are prevalent in non-ventilated hospital-acquired pneumonia
por: Shorr, Andrew F., et al.
Publicado: (2017)

Transient Acquired Hemophilia Associated with Mycoplasma Pneumoniae Pneumonia
por: Kim, Min Sun, et al.
Publicado: (2008)

EE388 Cost Effectiveness of Novel Antibiotic Ceftolozane/Tazobactam in Patients With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia in Greece
por: Yfantopoulos, N, et al.
Publicado: (2022)

Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: Risk factors and impact on outcomes
por: Piskin, Nihal, et al.
Publicado: (2012)

Community-Acquired Pneumonia and Hospital-Acquired Pneumonia in Adult Patients with Idiopathic Inflammatory Myopathy: Outcome and Antibiotic Therapy
por: Liang, Junyu, et al.
Publicado: (2020)

Combination antibiotic therapy for community-acquired pneumonia
por: Caballero, Jesus, et al.
Publicado: (2011)

Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
por: Torres, Antoni, et al.
Publicado: (2018)

Incidence of Antibiotic Treatment Failure in Patients with Nursing Home-Acquired Pneumonia and Community Acquired Pneumonia
por: Lopes, Mariana, et al.
Publicado: (2021)

Healthcare-Associated Pneumonia among Hospitalized Patients: Is It Different from Community Acquired Pneumonia?
por: Seong, Gil Myung, et al.
Publicado: (2014)

Prevention of hospital-acquired pneumonia in non-ventilated adult patients: a narrative review
por: Pássaro, Leonor, et al.
Publicado: (2016)

1477. Impact Of Resistance Thresholds On Mortality In Hospital-Acquired And Ventilator-Associated Pneumonia
por: Mazi, Patrick B, et al.
Publicado: (2020)

Correlation between chest radiographic findings and clinical features in hospitalized children with Mycoplasma pneumoniae pneumonia
por: Cho, Yeon Jin, et al.
Publicado: (2019)

Cefiderocol as a Treatment Option for Stenotrophomonas maltophilia Causing Hospital-Acquired/Ventilator-Associated Pneumonia
por: Rashid, Muhammad Humayoun, et al.
Publicado: (2023)

A multiplex pneumonia panel for diagnosis of hospital-acquired and ventilator-associated pneumonia in the era of emerging antimicrobial resistance
por: Jitmuang, Anupop, et al.
Publicado: (2022)

Early antibiotic treatment for gradual ventilator-associated pneumonia: yes or no?
por: Jiang, Xuandong, et al.
Publicado: (2016)

Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012–2019
por: Zilberberg, Marya D., et al.
Publicado: (2021)

1476. Objective Surveillance Definitions for Hospital-Acquired Pneumonia in Non-Ventilated Patients
por: Ji, Wenjing, et al.
Publicado: (2018)

Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia
por: Montravers, Philippe, et al.
Publicado: (2016)

Decrease in intravenous antibiotic use with adjunctive aerosolized amikacin treatment in intubated mechanically ventilated patients with Gram-negative pneumonia
por: Niederman, M, et al.
Publicado: (2007)

Comprehensive risk assessment for hospital-acquired pneumonia: sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia
por: Kim, Bo-Guen, et al.
Publicado: (2022)

Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea
por: Lee, Eun, et al.
Publicado: (2020)

Clinical review: Non-antibiotic strategies for preventing ventilator-associated pneumonia
por: Ferrer, Ricard, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_360d70ddbml8t2s3des1966g1u